Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gonadotropin-Releasing Hormone | 73 | 2023 | 1148 | 9.010 |
Why?
|
Puberty, Precocious | 21 | 2023 | 164 | 5.310 |
Why?
|
Receptors, LHRH | 34 | 2022 | 158 | 4.200 |
Why?
|
Puberty | 19 | 2023 | 501 | 3.550 |
Why?
|
Receptors, G-Protein-Coupled | 25 | 2022 | 1252 | 3.250 |
Why?
|
Luteinizing Hormone | 37 | 2023 | 820 | 3.200 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 14 | 2022 | 58 | 3.140 |
Why?
|
Hypogonadism | 27 | 2022 | 798 | 2.930 |
Why?
|
Sexual Maturation | 15 | 2023 | 261 | 2.880 |
Why?
|
Hypothalamus | 19 | 2023 | 999 | 2.740 |
Why?
|
Gonadotropins | 14 | 2022 | 241 | 2.310 |
Why?
|
Gonadotrophs | 6 | 2022 | 19 | 2.170 |
Why?
|
Follicle Stimulating Hormone | 23 | 2023 | 726 | 1.990 |
Why?
|
Reproduction | 10 | 2018 | 645 | 1.900 |
Why?
|
Ubiquitin-Protein Ligases | 17 | 2023 | 1899 | 1.890 |
Why?
|
Ribonucleoproteins | 9 | 2023 | 372 | 1.740 |
Why?
|
Pituitary Neoplasms | 19 | 2024 | 1323 | 1.610 |
Why?
|
Receptors, Peptide | 8 | 2022 | 279 | 1.510 |
Why?
|
Pituitary Diseases | 5 | 2023 | 135 | 1.210 |
Why?
|
Infertility | 4 | 2023 | 654 | 1.180 |
Why?
|
Gene Expression Regulation | 33 | 2022 | 11904 | 1.160 |
Why?
|
Pituitary Gland | 21 | 2023 | 635 | 1.110 |
Why?
|
Mutation, Missense | 8 | 2023 | 2571 | 1.080 |
Why?
|
Promoter Regions, Genetic | 26 | 2020 | 5790 | 1.010 |
Why?
|
Receptors, Neuropeptide | 4 | 2015 | 106 | 1.000 |
Why?
|
Receptors, Neurokinin-3 | 6 | 2022 | 59 | 0.980 |
Why?
|
Neurokinin B | 7 | 2022 | 67 | 0.960 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 3 | 2022 | 147 | 0.950 |
Why?
|
Adenoma | 14 | 2024 | 2163 | 0.930 |
Why?
|
Endocrinology | 3 | 2020 | 442 | 0.890 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1881 | 0.890 |
Why?
|
Activins | 6 | 2006 | 210 | 0.850 |
Why?
|
Cyclic AMP Response Element Modulator | 2 | 2016 | 88 | 0.840 |
Why?
|
Mullerian Ducts | 1 | 2023 | 203 | 0.840 |
Why?
|
Neurosecretory Systems | 2 | 2015 | 223 | 0.840 |
Why?
|
Pituitary ACTH Hypersecretion | 4 | 2021 | 179 | 0.800 |
Why?
|
Estradiol | 13 | 2024 | 1937 | 0.790 |
Why?
|
Chromogranins | 2 | 2022 | 161 | 0.780 |
Why?
|
Tachykinins | 4 | 2017 | 77 | 0.760 |
Why?
|
Signal Transduction | 23 | 2022 | 23447 | 0.760 |
Why?
|
Substance P | 4 | 2021 | 335 | 0.730 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 2 | 2022 | 195 | 0.720 |
Why?
|
Endocrine System Diseases | 3 | 2020 | 249 | 0.700 |
Why?
|
Animals | 103 | 2023 | 168475 | 0.690 |
Why?
|
Fertility | 6 | 2022 | 771 | 0.670 |
Why?
|
Genomic Imprinting | 2 | 2020 | 329 | 0.650 |
Why?
|
Endocrine System | 1 | 2020 | 114 | 0.640 |
Why?
|
Neurokinin A | 2 | 2017 | 32 | 0.640 |
Why?
|
COS Cells | 12 | 2022 | 1130 | 0.630 |
Why?
|
Neuropeptides | 6 | 2015 | 944 | 0.600 |
Why?
|
Neurons | 14 | 2022 | 9463 | 0.590 |
Why?
|
Inositol Phosphates | 8 | 2015 | 176 | 0.570 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2023 | 701 | 0.550 |
Why?
|
Calcium-Binding Proteins | 3 | 2023 | 1069 | 0.550 |
Why?
|
Infertility, Female | 2 | 2015 | 760 | 0.540 |
Why?
|
Mice | 52 | 2023 | 81539 | 0.530 |
Why?
|
Gonadal Disorders | 2 | 2016 | 5 | 0.520 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2016 | 473 | 0.510 |
Why?
|
HEK293 Cells | 9 | 2022 | 4281 | 0.510 |
Why?
|
Inhibin-beta Subunits | 3 | 2006 | 27 | 0.510 |
Why?
|
Infertility, Male | 2 | 2015 | 395 | 0.500 |
Why?
|
Mutation | 34 | 2023 | 30053 | 0.490 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 5 | 2015 | 615 | 0.490 |
Why?
|
Acromegaly | 3 | 2024 | 310 | 0.490 |
Why?
|
Transcriptional Activation | 7 | 2019 | 1756 | 0.490 |
Why?
|
Neuroendocrinology | 1 | 2014 | 5 | 0.490 |
Why?
|
Receptors, Notch | 1 | 2020 | 744 | 0.490 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2015 | 102 | 0.480 |
Why?
|
Adamantane | 1 | 2015 | 148 | 0.470 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 477 | 0.460 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 502 | 0.460 |
Why?
|
Transcription, Genetic | 12 | 2020 | 7593 | 0.450 |
Why?
|
Pituitary-Adrenal System | 2 | 2023 | 552 | 0.450 |
Why?
|
Receptors, Leptin | 2 | 2018 | 350 | 0.440 |
Why?
|
Insulinoma | 2 | 2011 | 121 | 0.440 |
Why?
|
Dipeptides | 1 | 2015 | 391 | 0.440 |
Why?
|
Testosterone | 15 | 2023 | 2472 | 0.430 |
Why?
|
Humans | 156 | 2024 | 761596 | 0.430 |
Why?
|
Contraception | 1 | 2016 | 349 | 0.430 |
Why?
|
Point Mutation | 6 | 2008 | 1595 | 0.420 |
Why?
|
Cell Line | 23 | 2022 | 15601 | 0.420 |
Why?
|
Glucocorticoids | 3 | 2020 | 2161 | 0.420 |
Why?
|
Tumor Suppressor Proteins | 5 | 2010 | 2805 | 0.420 |
Why?
|
Science | 1 | 2015 | 239 | 0.410 |
Why?
|
Female | 105 | 2024 | 392705 | 0.400 |
Why?
|
Neuronal Plasticity | 1 | 2021 | 1436 | 0.400 |
Why?
|
RNA, Messenger | 19 | 2023 | 12794 | 0.390 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2013 | 376 | 0.380 |
Why?
|
Thyroid Diseases | 4 | 2019 | 386 | 0.380 |
Why?
|
Response Elements | 4 | 2009 | 309 | 0.380 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1860 | 0.380 |
Why?
|
Frameshift Mutation | 1 | 2013 | 392 | 0.380 |
Why?
|
Gastrointestinal Hormones | 5 | 2012 | 101 | 0.370 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2021 | 1136 | 0.370 |
Why?
|
Cricetulus | 4 | 2015 | 814 | 0.360 |
Why?
|
CHO Cells | 5 | 2015 | 1387 | 0.360 |
Why?
|
Amenorrhea | 2 | 2013 | 483 | 0.360 |
Why?
|
Diabetes Insipidus | 2 | 2010 | 144 | 0.360 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 484 | 0.360 |
Why?
|
Mice, Knockout | 15 | 2022 | 14417 | 0.360 |
Why?
|
Binding Sites | 12 | 2019 | 6056 | 0.350 |
Why?
|
Research Personnel | 1 | 2015 | 588 | 0.350 |
Why?
|
Transcription Factor AP-1 | 3 | 2016 | 321 | 0.350 |
Why?
|
Leptin | 3 | 2021 | 1597 | 0.350 |
Why?
|
Ligands | 5 | 2010 | 3272 | 0.340 |
Why?
|
Feedback, Physiological | 1 | 2012 | 476 | 0.340 |
Why?
|
Neurosciences | 1 | 2014 | 367 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-jun | 3 | 2008 | 287 | 0.340 |
Why?
|
Calcium Signaling | 1 | 2013 | 733 | 0.320 |
Why?
|
Sp1 Transcription Factor | 2 | 2000 | 140 | 0.320 |
Why?
|
Luteinizing Hormone, beta Subunit | 4 | 2016 | 11 | 0.310 |
Why?
|
Male | 82 | 2024 | 360846 | 0.310 |
Why?
|
Cooperative Behavior | 2 | 2015 | 1505 | 0.310 |
Why?
|
Antibodies, Monoclonal | 3 | 2015 | 9177 | 0.310 |
Why?
|
Simian virus 40 | 1 | 2009 | 291 | 0.310 |
Why?
|
Base Sequence | 19 | 2008 | 12441 | 0.310 |
Why?
|
Transgenes | 2 | 2009 | 1010 | 0.310 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2009 | 257 | 0.300 |
Why?
|
Sleep Deprivation | 3 | 2024 | 846 | 0.300 |
Why?
|
Protein Precursors | 1 | 2012 | 1132 | 0.300 |
Why?
|
Ovary | 6 | 2015 | 959 | 0.300 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2008 | 151 | 0.290 |
Why?
|
Cell Membrane | 7 | 2022 | 3687 | 0.290 |
Why?
|
Membrane Proteins | 4 | 2023 | 7859 | 0.290 |
Why?
|
Pain Measurement | 1 | 2017 | 3551 | 0.290 |
Why?
|
Pancreas | 2 | 2011 | 1691 | 0.280 |
Why?
|
Rats | 25 | 2023 | 23741 | 0.280 |
Why?
|
Hypoglycemia | 2 | 2011 | 883 | 0.280 |
Why?
|
Puberty, Delayed | 5 | 2014 | 121 | 0.270 |
Why?
|
Chorionic Gonadotropin | 3 | 2023 | 457 | 0.270 |
Why?
|
Protein Transport | 3 | 2022 | 1967 | 0.270 |
Why?
|
Testis | 5 | 2018 | 794 | 0.270 |
Why?
|
Molecular Sequence Data | 21 | 2015 | 17635 | 0.270 |
Why?
|
Transfection | 13 | 2010 | 5774 | 0.260 |
Why?
|
Hypothalamic Diseases | 3 | 2023 | 134 | 0.260 |
Why?
|
Research | 1 | 2014 | 1982 | 0.260 |
Why?
|
Homeodomain Proteins | 5 | 2004 | 2418 | 0.260 |
Why?
|
Inhibins | 2 | 2004 | 210 | 0.260 |
Why?
|
Transcription Factors | 8 | 2010 | 12130 | 0.250 |
Why?
|
Spermatogenesis | 2 | 2017 | 259 | 0.250 |
Why?
|
DNA-Binding Proteins | 9 | 2012 | 9610 | 0.250 |
Why?
|
Genes, Dominant | 4 | 2013 | 852 | 0.250 |
Why?
|
DNA | 11 | 2021 | 7213 | 0.250 |
Why?
|
Cricetinae | 4 | 2013 | 2423 | 0.240 |
Why?
|
CCAAT-Binding Factor | 1 | 2004 | 21 | 0.240 |
Why?
|
Carcinoma, Small Cell | 3 | 1997 | 420 | 0.230 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 934 | 0.230 |
Why?
|
Uterus | 2 | 2023 | 649 | 0.230 |
Why?
|
Hydrocortisone | 2 | 2023 | 1819 | 0.230 |
Why?
|
Computational Biology | 2 | 2016 | 3517 | 0.230 |
Why?
|
Early Growth Response Protein 1 | 4 | 2018 | 133 | 0.230 |
Why?
|
Castration | 2 | 2022 | 151 | 0.220 |
Why?
|
Receptors, FSH | 1 | 2003 | 29 | 0.220 |
Why?
|
Genetic Vectors | 4 | 2007 | 3396 | 0.220 |
Why?
|
Extraterrestrial Environment | 1 | 2023 | 25 | 0.220 |
Why?
|
Mars | 1 | 2023 | 28 | 0.210 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2003 | 47 | 0.210 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2244 | 0.210 |
Why?
|
Receptors, Tachykinin | 2 | 2014 | 25 | 0.210 |
Why?
|
Prolactinoma | 1 | 2023 | 114 | 0.210 |
Why?
|
Histone Demethylases | 2 | 2019 | 323 | 0.210 |
Why?
|
Hypopituitarism | 3 | 2017 | 250 | 0.210 |
Why?
|
Hyperprolactinemia | 1 | 2023 | 124 | 0.200 |
Why?
|
Sex Characteristics | 5 | 2018 | 2639 | 0.200 |
Why?
|
Germany | 3 | 2024 | 875 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.200 |
Why?
|
Luciferases | 7 | 2003 | 714 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Premenopause | 2 | 2024 | 1039 | 0.200 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 5368 | 0.200 |
Why?
|
Receptors, Glucocorticoid | 3 | 2019 | 305 | 0.200 |
Why?
|
Ovariectomy | 4 | 2023 | 614 | 0.200 |
Why?
|
Illusions | 1 | 2022 | 61 | 0.200 |
Why?
|
Muscular Disorders, Atrophic | 1 | 2021 | 24 | 0.190 |
Why?
|
Glycosylation | 2 | 2017 | 1097 | 0.190 |
Why?
|
Binding, Competitive | 2 | 2013 | 1141 | 0.190 |
Why?
|
Rett Syndrome | 1 | 2023 | 164 | 0.190 |
Why?
|
Thyrotoxicosis | 2 | 2019 | 85 | 0.190 |
Why?
|
Herpesvirus 1, Human | 1 | 2007 | 753 | 0.190 |
Why?
|
Models, Theoretical | 1 | 2013 | 3575 | 0.190 |
Why?
|
Cryptorchidism | 1 | 2022 | 151 | 0.190 |
Why?
|
Heterozygote | 6 | 2013 | 2787 | 0.190 |
Why?
|
Protein Binding | 7 | 2012 | 9353 | 0.190 |
Why?
|
HeLa Cells | 4 | 2022 | 3094 | 0.180 |
Why?
|
Endometrium | 1 | 2023 | 403 | 0.180 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 2 | 1998 | 95 | 0.180 |
Why?
|
Phenotype | 13 | 2022 | 16592 | 0.180 |
Why?
|
Body Constitution | 1 | 2021 | 273 | 0.180 |
Why?
|
Environmental Pollution | 1 | 2021 | 124 | 0.180 |
Why?
|
Gene Expression | 7 | 2016 | 7581 | 0.180 |
Why?
|
Immediate-Early Proteins | 2 | 2000 | 449 | 0.180 |
Why?
|
Standard of Care | 1 | 2024 | 551 | 0.180 |
Why?
|
Golgi Apparatus | 1 | 2022 | 405 | 0.180 |
Why?
|
Rodentia | 1 | 2021 | 262 | 0.170 |
Why?
|
Proteins | 2 | 2005 | 6032 | 0.170 |
Why?
|
Phosphorylation | 5 | 2013 | 8321 | 0.170 |
Why?
|
Glycoproteins | 4 | 2003 | 2203 | 0.170 |
Why?
|
Histones | 3 | 2019 | 2580 | 0.170 |
Why?
|
Cushing Syndrome | 1 | 2021 | 241 | 0.170 |
Why?
|
Computer Simulation | 1 | 2013 | 6241 | 0.170 |
Why?
|
Men's Health | 1 | 2020 | 73 | 0.170 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2017 | 134 | 0.170 |
Why?
|
GTP-Binding Proteins | 3 | 1994 | 951 | 0.170 |
Why?
|
Pituitary Gland, Anterior | 3 | 1998 | 142 | 0.170 |
Why?
|
Prednisone | 4 | 2019 | 1563 | 0.170 |
Why?
|
MAP Kinase Signaling System | 2 | 2004 | 1486 | 0.160 |
Why?
|
Amino Acid Sequence | 10 | 2015 | 13446 | 0.160 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 2 | 2021 | 63 | 0.160 |
Why?
|
Pedigree | 8 | 2018 | 4542 | 0.160 |
Why?
|
Follistatin | 5 | 2004 | 137 | 0.160 |
Why?
|
Adult | 42 | 2024 | 221210 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2016 | 641 | 0.160 |
Why?
|
Confusion | 2 | 2011 | 278 | 0.160 |
Why?
|
Addison Disease | 1 | 2019 | 48 | 0.160 |
Why?
|
Growth Disorders | 2 | 2014 | 655 | 0.150 |
Why?
|
Ventromedial Hypothalamic Nucleus | 1 | 2018 | 46 | 0.150 |
Why?
|
Respiration Disorders | 1 | 2021 | 367 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 2008 | 586 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 362 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2009 | 257 | 0.150 |
Why?
|
Cells, Cultured | 11 | 2016 | 18966 | 0.150 |
Why?
|
Sex Factors | 6 | 2021 | 10554 | 0.150 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 194 | 0.150 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2018 | 88 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2012 | 3792 | 0.150 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 751 | 0.140 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2018 | 108 | 0.140 |
Why?
|
Enzyme Activation | 4 | 2013 | 3597 | 0.140 |
Why?
|
Burkitt Lymphoma | 1 | 1999 | 335 | 0.140 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2018 | 302 | 0.140 |
Why?
|
Mice, Inbred C57BL | 5 | 2022 | 22174 | 0.140 |
Why?
|
Hypothyroidism | 2 | 2019 | 668 | 0.140 |
Why?
|
Pulsatile Flow | 3 | 2005 | 321 | 0.140 |
Why?
|
Blotting, Western | 4 | 2013 | 5035 | 0.140 |
Why?
|
Social Security | 1 | 2017 | 101 | 0.140 |
Why?
|
Receptors, Virus | 1 | 2020 | 640 | 0.140 |
Why?
|
Conserved Sequence | 1 | 2020 | 1163 | 0.130 |
Why?
|
Oligopeptides | 2 | 2015 | 1187 | 0.130 |
Why?
|
Trans-Activators | 2 | 2004 | 2856 | 0.130 |
Why?
|
Calcium | 6 | 2015 | 5722 | 0.130 |
Why?
|
Fatigue | 1 | 2023 | 1552 | 0.130 |
Why?
|
Psychomotor Performance | 1 | 2024 | 1882 | 0.130 |
Why?
|
Endoplasmic Reticulum | 1 | 2022 | 1134 | 0.130 |
Why?
|
Rehabilitation | 1 | 2017 | 130 | 0.130 |
Why?
|
Androgens | 2 | 2021 | 1286 | 0.130 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13642 | 0.130 |
Why?
|
Galactose | 1 | 2017 | 297 | 0.130 |
Why?
|
Gonadotropins, Pituitary | 1 | 2015 | 69 | 0.130 |
Why?
|
Receptors, Steroid | 1 | 1996 | 156 | 0.130 |
Why?
|
DNA Topoisomerases, Type II | 1 | 1996 | 122 | 0.130 |
Why?
|
Genitalia, Male | 1 | 2015 | 87 | 0.130 |
Why?
|
Human Growth Hormone | 1 | 2020 | 642 | 0.130 |
Why?
|
DNA Mutational Analysis | 7 | 2016 | 4111 | 0.130 |
Why?
|
Insurance | 1 | 2017 | 113 | 0.120 |
Why?
|
Adolescent | 18 | 2023 | 88326 | 0.120 |
Why?
|
Radioligand Assay | 1 | 2015 | 366 | 0.120 |
Why?
|
Malnutrition | 1 | 2022 | 645 | 0.120 |
Why?
|
Pregnancy | 5 | 2023 | 29890 | 0.120 |
Why?
|
Climate Change | 1 | 2021 | 501 | 0.120 |
Why?
|
Child | 15 | 2023 | 80158 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2003 | 1858 | 0.120 |
Why?
|
Genetic Association Studies | 5 | 2021 | 2735 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 683 | 0.120 |
Why?
|
Receptors, Thyrotropin-Releasing Hormone | 1 | 1994 | 8 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 5 | 2020 | 8181 | 0.120 |
Why?
|
Ovulation | 1 | 2015 | 181 | 0.120 |
Why?
|
PubMed | 1 | 2015 | 129 | 0.120 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1994 | 139 | 0.120 |
Why?
|
Genitalia, Female | 1 | 2015 | 147 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 276 | 0.120 |
Why?
|
Immunoprecipitation | 2 | 2021 | 878 | 0.120 |
Why?
|
Arrestins | 1 | 2014 | 73 | 0.120 |
Why?
|
Models, Animal | 3 | 2017 | 2112 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 790 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2006 | 2986 | 0.110 |
Why?
|
Hominidae | 1 | 1994 | 68 | 0.110 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2015 | 150 | 0.110 |
Why?
|
Models, Biological | 7 | 2012 | 9469 | 0.110 |
Why?
|
Attention | 1 | 2024 | 2396 | 0.110 |
Why?
|
Immunohistochemistry | 7 | 2016 | 11076 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2024 | 11742 | 0.110 |
Why?
|
Sperm Count | 3 | 2020 | 229 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 549 | 0.110 |
Why?
|
Biomedical Research | 2 | 2020 | 3429 | 0.110 |
Why?
|
Dioxygenases | 2 | 2012 | 345 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1039 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 2 | 2012 | 1974 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1065 | 0.110 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1516 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1994 | 375 | 0.110 |
Why?
|
Genetic Load | 1 | 2012 | 15 | 0.100 |
Why?
|
Paired Box Transcription Factors | 2 | 2004 | 206 | 0.100 |
Why?
|
Diestrus | 1 | 1992 | 5 | 0.100 |
Why?
|
Middle Aged | 29 | 2024 | 220921 | 0.100 |
Why?
|
Estrogens | 2 | 2017 | 1522 | 0.100 |
Why?
|
Coenzymes | 1 | 2012 | 102 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1363 | 0.100 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2012 | 110 | 0.100 |
Why?
|
Blastocyst | 1 | 2015 | 433 | 0.100 |
Why?
|
Fructose Intolerance | 1 | 1991 | 8 | 0.100 |
Why?
|
Health | 1 | 2015 | 398 | 0.100 |
Why?
|
Authorship | 1 | 2015 | 284 | 0.100 |
Why?
|
Alcohol Oxidoreductases | 1 | 2012 | 169 | 0.100 |
Why?
|
Salvage Therapy | 1 | 1999 | 1263 | 0.100 |
Why?
|
Drug Administration Schedule | 4 | 2017 | 4853 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2008 | 2065 | 0.100 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 1991 | 51 | 0.100 |
Why?
|
DNA, Complementary | 4 | 1998 | 1991 | 0.100 |
Why?
|
Neoplasms | 5 | 2019 | 22173 | 0.100 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 455 | 0.100 |
Why?
|
Bicarbonates | 2 | 1992 | 292 | 0.100 |
Why?
|
Iodine Radioisotopes | 1 | 2015 | 1031 | 0.100 |
Why?
|
Sequence Analysis, DNA | 5 | 2019 | 4740 | 0.100 |
Why?
|
Genome-Wide Association Study | 3 | 2020 | 12690 | 0.100 |
Why?
|
Epithelial Cells | 1 | 2023 | 3677 | 0.100 |
Why?
|
Ghrelin | 1 | 2013 | 252 | 0.100 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2015 | 793 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 1 | 2015 | 702 | 0.100 |
Why?
|
Endopeptidases | 1 | 2015 | 774 | 0.090 |
Why?
|
Cytosine | 1 | 2012 | 211 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2020 | 1886 | 0.090 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2013 | 421 | 0.090 |
Why?
|
Diazoxide | 1 | 2011 | 52 | 0.090 |
Why?
|
Polymerase Chain Reaction | 7 | 2021 | 6075 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2019 | 3415 | 0.090 |
Why?
|
Chromatin | 2 | 2021 | 2961 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 1999 | 1378 | 0.090 |
Why?
|
Brazil | 4 | 2023 | 1230 | 0.090 |
Why?
|
Luminescent Proteins | 1 | 2013 | 837 | 0.090 |
Why?
|
Gene Targeting | 2 | 2007 | 838 | 0.090 |
Why?
|
Vasodilator Agents | 2 | 2011 | 973 | 0.090 |
Why?
|
Research Support as Topic | 1 | 2015 | 697 | 0.090 |
Why?
|
Potassium | 2 | 1992 | 1311 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor, Endocrine-Gland-Derived | 1 | 2010 | 3 | 0.090 |
Why?
|
Cohort Studies | 9 | 2023 | 41495 | 0.090 |
Why?
|
Echocardiography | 1 | 2023 | 4989 | 0.090 |
Why?
|
Nevus | 1 | 2012 | 205 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1999 | 1551 | 0.090 |
Why?
|
Embryonic Development | 1 | 2015 | 721 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2065 | 0.090 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2010 | 87 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
Olfaction Disorders | 2 | 2010 | 224 | 0.090 |
Why?
|
Polysaccharides | 1 | 2017 | 1014 | 0.090 |
Why?
|
Xenopus Proteins | 1 | 2012 | 434 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1651 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 4 | 2002 | 3733 | 0.080 |
Why?
|
Peptide Fragments | 3 | 2021 | 5112 | 0.080 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 931 | 0.080 |
Why?
|
Hyperkalemia | 1 | 1992 | 233 | 0.080 |
Why?
|
Somatostatinoma | 1 | 1989 | 10 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 1406 | 0.080 |
Why?
|
Adenoma, Islet Cell | 1 | 1989 | 72 | 0.080 |
Why?
|
Kallmann Syndrome | 1 | 2010 | 139 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2003 | 2947 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9542 | 0.080 |
Why?
|
Estrous Cycle | 1 | 2009 | 65 | 0.080 |
Why?
|
Pseudotumor Cerebri | 1 | 2010 | 108 | 0.080 |
Why?
|
RNA Splice Sites | 1 | 2010 | 211 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4576 | 0.080 |
Why?
|
Prolactin | 3 | 2023 | 625 | 0.080 |
Why?
|
Upstream Stimulatory Factors | 1 | 2008 | 18 | 0.080 |
Why?
|
Eye | 1 | 2012 | 712 | 0.080 |
Why?
|
Duodenal Neoplasms | 1 | 1989 | 114 | 0.080 |
Why?
|
Xenopus laevis | 1 | 2012 | 963 | 0.080 |
Why?
|
Homozygote | 3 | 2010 | 1776 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2013 | 983 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 2 | 2010 | 829 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2020 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 2691 | 0.080 |
Why?
|
Protein Kinase C | 3 | 1999 | 1202 | 0.080 |
Why?
|
Peptides | 3 | 2015 | 4358 | 0.080 |
Why?
|
Aged | 17 | 2024 | 169310 | 0.080 |
Why?
|
Buserelin | 4 | 2014 | 16 | 0.080 |
Why?
|
Adenosine Monophosphate | 1 | 2009 | 231 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.080 |
Why?
|
Lysine | 1 | 2012 | 993 | 0.080 |
Why?
|
CREB-Binding Protein | 1 | 2008 | 148 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 59260 | 0.080 |
Why?
|
Dizziness | 1 | 2011 | 259 | 0.070 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9420 | 0.070 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2008 | 101 | 0.070 |
Why?
|
Inclusion Bodies | 1 | 1989 | 281 | 0.070 |
Why?
|
Plasmids | 2 | 2003 | 2269 | 0.070 |
Why?
|
Autocrine Communication | 1 | 2008 | 169 | 0.070 |
Why?
|
Gene Deletion | 3 | 2017 | 2665 | 0.070 |
Why?
|
Receptors, Chemokine | 2 | 2007 | 652 | 0.070 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 915 | 0.070 |
Why?
|
Cell Count | 2 | 2008 | 1835 | 0.070 |
Why?
|
Orchiectomy | 2 | 2023 | 463 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1898 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2169 | 0.070 |
Why?
|
Paracrine Communication | 1 | 2008 | 277 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2467 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2645 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1900 | 0.070 |
Why?
|
Preoptic Area | 1 | 2007 | 132 | 0.070 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1739 | 0.070 |
Why?
|
Mutant Proteins | 1 | 2008 | 491 | 0.070 |
Why?
|
Cell Size | 1 | 2008 | 624 | 0.070 |
Why?
|
Histone Acetyltransferases | 1 | 2008 | 336 | 0.070 |
Why?
|
Neurogenesis | 1 | 2012 | 863 | 0.070 |
Why?
|
Fushi Tarazu Transcription Factors | 3 | 2000 | 24 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 1994 | 4615 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8527 | 0.060 |
Why?
|
Butadienes | 1 | 2005 | 107 | 0.060 |
Why?
|
Steroidogenic Factor 1 | 3 | 2000 | 45 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2010 | 625 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7391 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2000 | 858 | 0.060 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2006 | 1374 | 0.060 |
Why?
|
Lysosomes | 1 | 2011 | 924 | 0.060 |
Why?
|
Electrophysiology | 1 | 2008 | 1262 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2023 | 80647 | 0.060 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2006 | 318 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3188 | 0.060 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2004 | 30 | 0.060 |
Why?
|
Melanoma | 2 | 2014 | 5709 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2017 | 4544 | 0.060 |
Why?
|
Muscle, Skeletal | 3 | 2023 | 4948 | 0.060 |
Why?
|
Menopause | 2 | 2023 | 1646 | 0.060 |
Why?
|
Lung Neoplasms | 4 | 1997 | 13381 | 0.060 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.060 |
Why?
|
Prognosis | 6 | 2024 | 29629 | 0.060 |
Why?
|
Prospective Studies | 8 | 2024 | 54423 | 0.060 |
Why?
|
Smad2 Protein | 1 | 2004 | 145 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3462 | 0.060 |
Why?
|
Smad3 Protein | 1 | 2004 | 166 | 0.060 |
Why?
|
Vincristine | 3 | 2006 | 1036 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 293 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1463 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15266 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2006 | 605 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1749 | 0.060 |
Why?
|
Somatostatin | 2 | 2020 | 447 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 1999 | 5672 | 0.060 |
Why?
|
Genetic Markers | 1 | 2010 | 2601 | 0.060 |
Why?
|
Disorders of Sex Development | 1 | 2004 | 129 | 0.060 |
Why?
|
Osmolar Concentration | 2 | 2003 | 659 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3816 | 0.050 |
Why?
|
Placenta | 1 | 2013 | 1709 | 0.050 |
Why?
|
Protein Folding | 1 | 2007 | 870 | 0.050 |
Why?
|
Chemotaxis | 1 | 2006 | 598 | 0.050 |
Why?
|
Smad4 Protein | 1 | 2004 | 191 | 0.050 |
Why?
|
Gonadal Hormones | 1 | 2023 | 30 | 0.050 |
Why?
|
Child, Preschool | 6 | 2021 | 42232 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4762 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4652 | 0.050 |
Why?
|
Testicular Hormones | 1 | 2003 | 188 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18399 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2007 | 754 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 22176 | 0.050 |
Why?
|
Models, Molecular | 1 | 2012 | 5439 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 39969 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.050 |
Why?
|
Kinetics | 3 | 2002 | 6374 | 0.050 |
Why?
|
Smell | 2 | 2001 | 259 | 0.050 |
Why?
|
Growth Inhibitors | 1 | 2003 | 378 | 0.050 |
Why?
|
Electrophoresis | 1 | 2002 | 227 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2023 | 826 | 0.050 |
Why?
|
Calorimetry, Indirect | 1 | 2022 | 174 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5337 | 0.050 |
Why?
|
Smad Proteins | 1 | 2002 | 156 | 0.050 |
Why?
|
Restriction Mapping | 2 | 1992 | 851 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3076 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2004 | 10766 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2004 | 855 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5841 | 0.050 |
Why?
|
Hindlimb Suspension | 1 | 2021 | 75 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 64685 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 933 | 0.050 |
Why?
|
Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 2 | 1993 | 1302 | 0.050 |
Why?
|
RNA Interference | 1 | 2009 | 2832 | 0.050 |
Why?
|
Androstenedione | 1 | 2021 | 131 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2005 | 2264 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15936 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11122 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 1997 | 5314 | 0.050 |
Why?
|
Dopamine Agonists | 1 | 2023 | 352 | 0.050 |
Why?
|
Insulin | 2 | 2013 | 6597 | 0.050 |
Why?
|
Cyclophosphamide | 3 | 2006 | 2220 | 0.050 |
Why?
|
3T3 Cells | 1 | 2002 | 1085 | 0.050 |
Why?
|
Tumor Cells, Cultured | 4 | 1997 | 6131 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 8554 | 0.040 |
Why?
|
Perfusion | 1 | 2005 | 1373 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 779 | 0.040 |
Why?
|
Receptors, Somatotropin | 1 | 2020 | 58 | 0.040 |
Why?
|
Biology | 1 | 2022 | 290 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1999 | 817 | 0.040 |
Why?
|
Carbohydrates | 1 | 2022 | 390 | 0.040 |
Why?
|
Nitriles | 1 | 2005 | 971 | 0.040 |
Why?
|
Reference Values | 4 | 2009 | 4920 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
Nerve Tissue Proteins | 2 | 2010 | 4415 | 0.040 |
Why?
|
Recombinant Proteins | 3 | 2000 | 6534 | 0.040 |
Why?
|
Growth Hormone | 1 | 2022 | 569 | 0.040 |
Why?
|
Genotype | 3 | 2011 | 12990 | 0.040 |
Why?
|
Quality of Life | 4 | 2022 | 13367 | 0.040 |
Why?
|
Protein Conformation | 1 | 2007 | 3968 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12149 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2022 | 554 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58984 | 0.040 |
Why?
|
Blotting, Northern | 3 | 2003 | 1545 | 0.040 |
Why?
|
Cell Movement | 2 | 2008 | 5205 | 0.040 |
Why?
|
Saliva | 1 | 2023 | 828 | 0.040 |
Why?
|
Gels | 1 | 2020 | 420 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3801 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2022 | 2882 | 0.040 |
Why?
|
Methylation | 2 | 2012 | 1084 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 869 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2021 | 334 | 0.040 |
Why?
|
Calcium Channel Agonists | 1 | 1998 | 26 | 0.040 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 73 | 0.040 |
Why?
|
Ubiquitination | 1 | 2023 | 1007 | 0.040 |
Why?
|
DNA Footprinting | 1 | 1998 | 97 | 0.040 |
Why?
|
Receptors, Growth Factor | 2 | 1996 | 326 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 477 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2021 | 550 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2003 | 1699 | 0.040 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2018 | 56 | 0.040 |
Why?
|
Lymphatic Diseases | 2 | 2010 | 320 | 0.040 |
Why?
|
Reaction Time | 1 | 2024 | 2089 | 0.040 |
Why?
|
Doxorubicin | 2 | 2006 | 2224 | 0.040 |
Why?
|
Endocrine Glands | 1 | 2018 | 102 | 0.040 |
Why?
|
Consensus Sequence | 1 | 1998 | 365 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 43 | 0.040 |
Why?
|
Circadian Rhythm | 2 | 2021 | 2576 | 0.040 |
Why?
|
Recurrence | 2 | 2021 | 8466 | 0.040 |
Why?
|
Sleep | 2 | 2023 | 4768 | 0.030 |
Why?
|
Liver | 1 | 1992 | 7528 | 0.030 |
Why?
|
Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
Adenoviridae | 1 | 2001 | 1085 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39106 | 0.030 |
Why?
|
Fertility Agents, Female | 1 | 2017 | 101 | 0.030 |
Why?
|
Goserelin | 1 | 2017 | 126 | 0.030 |
Why?
|
Mice, Obese | 1 | 2017 | 420 | 0.030 |
Why?
|
Activin Receptors | 3 | 2006 | 40 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5672 | 0.030 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2017 | 132 | 0.030 |
Why?
|
Sperm Motility | 1 | 2017 | 266 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 3810 | 0.030 |
Why?
|
Alprostadil | 1 | 1996 | 86 | 0.030 |
Why?
|
Risk Factors | 5 | 2024 | 74213 | 0.030 |
Why?
|
Myeloma Proteins | 1 | 1996 | 71 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2022 | 2231 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 662 | 0.030 |
Why?
|
Palatine Tonsil | 1 | 1996 | 193 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1814 | 0.030 |
Why?
|
Receptors, CCR2 | 2 | 2007 | 215 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1206 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2002 | 2910 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2017 | 276 | 0.030 |
Why?
|
Electrophysiological Phenomena | 1 | 2017 | 307 | 0.030 |
Why?
|
Dyspnea | 1 | 2023 | 1347 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 1996 | 302 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3430 | 0.030 |
Why?
|
Leuprolide | 1 | 2017 | 312 | 0.030 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1994 | 20 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2397 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3713 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36426 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1998 | 694 | 0.030 |
Why?
|
Prader-Willi Syndrome | 1 | 2015 | 78 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2010 | 5799 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2023 | 12973 | 0.030 |
Why?
|
Genomics | 1 | 2010 | 5821 | 0.030 |
Why?
|
Survival Rate | 4 | 2019 | 12723 | 0.030 |
Why?
|
Mutagenesis | 1 | 1998 | 1232 | 0.030 |
Why?
|
Lymphoma, Follicular | 1 | 1998 | 457 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 1999 | 2115 | 0.030 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 1994 | 201 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2822 | 0.030 |
Why?
|
DNA Primers | 2 | 1997 | 2820 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1995 | 1434 | 0.030 |
Why?
|
Paraproteinemias | 1 | 1996 | 248 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2007 | 3964 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2017 | 513 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1218 | 0.030 |
Why?
|
Models, Structural | 1 | 1992 | 340 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 1935 | 0.030 |
Why?
|
Enzyme Stability | 1 | 2012 | 219 | 0.030 |
Why?
|
Alleles | 1 | 2023 | 6864 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18255 | 0.020 |
Why?
|
Gene Frequency | 2 | 2014 | 3606 | 0.020 |
Why?
|
5-Methylcytosine | 1 | 2012 | 148 | 0.020 |
Why?
|
Pilot Projects | 2 | 2023 | 8633 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2014 | 341 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3124 | 0.020 |
Why?
|
Isoenzymes | 1 | 1996 | 1687 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1058 | 0.020 |
Why?
|
Biopsy | 2 | 2010 | 6766 | 0.020 |
Why?
|
S100 Proteins | 1 | 1992 | 218 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 1996 | 1129 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2684 | 0.020 |
Why?
|
Oncogenes | 1 | 2017 | 1222 | 0.020 |
Why?
|
Somatomedins | 1 | 1992 | 179 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1257 | 0.020 |
Why?
|
Anions | 1 | 1991 | 136 | 0.020 |
Why?
|
United States | 2 | 2019 | 72340 | 0.020 |
Why?
|
Fathers | 1 | 2014 | 376 | 0.020 |
Why?
|
Leg | 1 | 1996 | 1088 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2088 | 0.020 |
Why?
|
Genes | 1 | 1994 | 1823 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2358 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2022 | 3313 | 0.020 |
Why?
|
Polyuria | 1 | 2010 | 37 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4174 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 1996 | 1079 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26129 | 0.020 |
Why?
|
Family | 1 | 2021 | 3195 | 0.020 |
Why?
|
Genes, Recessive | 2 | 2003 | 623 | 0.020 |
Why?
|
Autoimmunity | 1 | 2018 | 1356 | 0.020 |
Why?
|
Electron Probe Microanalysis | 1 | 1989 | 32 | 0.020 |
Why?
|
Apatites | 1 | 1989 | 19 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 1992 | 1229 | 0.020 |
Why?
|
Xerostomia | 1 | 2010 | 94 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2072 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1809 | 0.020 |
Why?
|
Anorexia | 1 | 2010 | 154 | 0.020 |
Why?
|
Gene Library | 1 | 1992 | 1059 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2023 | 3530 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2010 | 464 | 0.020 |
Why?
|
Melanocytes | 1 | 2012 | 509 | 0.020 |
Why?
|
Penis | 1 | 2010 | 212 | 0.020 |
Why?
|
Radiosurgery | 1 | 1998 | 1342 | 0.020 |
Why?
|
Exons | 2 | 2010 | 2391 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4028 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2009 | 456 | 0.020 |
Why?
|
Diabetic Ketoacidosis | 1 | 1992 | 253 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1791 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1994 | 2341 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2010 | 285 | 0.020 |
Why?
|
Receptors, Thyrotropin | 1 | 1988 | 45 | 0.020 |
Why?
|
Polymorphism, Genetic | 2 | 2001 | 4243 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1996 | 1993 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8710 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3612 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2010 | 3465 | 0.020 |
Why?
|
Microsomes | 1 | 1988 | 251 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9280 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1996 | 2209 | 0.020 |
Why?
|
Age of Onset | 1 | 2015 | 3306 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 1741 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1990 | 0.020 |
Why?
|
Postmenopause | 1 | 2017 | 2513 | 0.020 |
Why?
|
Receptors, CCR10 | 1 | 2007 | 9 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 592 | 0.020 |
Why?
|
Vinblastine | 1 | 2008 | 488 | 0.020 |
Why?
|
Organ Specificity | 1 | 1992 | 1968 | 0.020 |
Why?
|
Ischemia | 1 | 1996 | 1884 | 0.020 |
Why?
|
Receptors, CCR4 | 1 | 2007 | 77 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 666 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14608 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1971 | 0.020 |
Why?
|
Antigens, CD | 1 | 1997 | 4001 | 0.020 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2006 | 25 | 0.020 |
Why?
|
RNA | 1 | 1996 | 2725 | 0.020 |
Why?
|
Early Growth Response Protein 2 | 1 | 2006 | 25 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 938 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 682 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 825 | 0.020 |
Why?
|
Carboxypeptidases | 1 | 2006 | 154 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21355 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1989 | 2561 | 0.020 |
Why?
|
Carboplatin | 1 | 2008 | 794 | 0.020 |
Why?
|
Prednisolone | 1 | 2006 | 326 | 0.020 |
Why?
|
Ethylnitrosourea | 1 | 2004 | 51 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 1835 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2007 | 411 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 9032 | 0.020 |
Why?
|
Etoposide | 1 | 2006 | 634 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3639 | 0.010 |
Why?
|
Sex Differentiation | 1 | 2004 | 73 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14665 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 867 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2006 | 422 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2008 | 877 | 0.010 |
Why?
|
Autoantigens | 1 | 1988 | 891 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 454 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 457 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1422 | 0.010 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2007 | 542 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2006 | 413 | 0.010 |
Why?
|
Gonads | 1 | 2003 | 109 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1995 | 1640 | 0.010 |
Why?
|
Tubulin | 1 | 2007 | 693 | 0.010 |
Why?
|
Lod Score | 1 | 2003 | 600 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 909 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21019 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2915 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2677 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2017 | 4331 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1988 | 1170 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36193 | 0.010 |
Why?
|
Paclitaxel | 1 | 2008 | 1732 | 0.010 |
Why?
|
Depression | 1 | 2021 | 8126 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16990 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 2003 | 407 | 0.010 |
Why?
|
Calcinosis | 1 | 1989 | 1469 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4514 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 2557 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6965 | 0.010 |
Why?
|
Prednimustine | 1 | 1998 | 1 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20100 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1992 | 4937 | 0.010 |
Why?
|
Mitoxantrone | 1 | 1998 | 148 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4125 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1996 | 5146 | 0.010 |
Why?
|
Lung | 1 | 1996 | 10002 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3779 | 0.010 |
Why?
|
Genetic Testing | 1 | 2010 | 3537 | 0.010 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1997 | 89 | 0.010 |
Why?
|
Carcinoma, Large Cell | 1 | 1997 | 113 | 0.010 |
Why?
|
Health Surveys | 1 | 2006 | 4061 | 0.010 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 1996 | 34 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 225 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1996 | 239 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4352 | 0.010 |
Why?
|
Haplorhini | 1 | 1996 | 525 | 0.010 |
Why?
|
Gallopamil | 1 | 1994 | 5 | 0.010 |
Why?
|
Glucose | 1 | 2007 | 4347 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2006 | 3701 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1996 | 329 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 1997 | 629 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6567 | 0.010 |
Why?
|
Diltiazem | 1 | 1994 | 131 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3085 | 0.010 |
Why?
|
Cycloheximide | 1 | 1994 | 343 | 0.010 |
Why?
|
Ribonucleases | 1 | 1994 | 277 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12463 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 1994 | 202 | 0.010 |
Why?
|
Growth Substances | 1 | 1996 | 768 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1994 | 214 | 0.010 |
Why?
|
Molecular Probes | 1 | 1994 | 309 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 1996 | 496 | 0.010 |
Why?
|
Cholera Toxin | 1 | 1994 | 559 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1997 | 1093 | 0.010 |
Why?
|
Fludrocortisone | 1 | 1991 | 24 | 0.010 |
Why?
|
Microcirculation | 1 | 1996 | 1272 | 0.010 |
Why?
|
Acetazolamide | 1 | 1991 | 96 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1992 | 208 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1994 | 1463 | 0.010 |
Why?
|
Sulfates | 1 | 1991 | 380 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26202 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2007 | 11530 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 2186 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4465 | 0.010 |
Why?
|
Extracellular Space | 1 | 1991 | 563 | 0.010 |
Why?
|
Drug Resistance | 1 | 1995 | 1596 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2112 | 0.000 |
Why?
|
Antibodies, Protozoan | 1 | 1990 | 252 | 0.000 |
Why?
|
Toxoplasma | 1 | 1990 | 157 | 0.000 |
Why?
|
Orthomyxoviridae | 1 | 1990 | 149 | 0.000 |
Why?
|
Chlorides | 1 | 1991 | 665 | 0.000 |
Why?
|
Brain | 2 | 2010 | 27121 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17904 | 0.000 |
Why?
|
Leukocytes, Mononuclear | 1 | 1995 | 1844 | 0.000 |
Why?
|
Disease-Free Survival | 1 | 1998 | 6815 | 0.000 |
Why?
|
Autoradiography | 1 | 1988 | 728 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1996 | 6228 | 0.000 |
Why?
|
Down-Regulation | 1 | 1994 | 2919 | 0.000 |
Why?
|
Hyperplasia | 1 | 1990 | 1152 | 0.000 |
Why?
|
Lymphoma | 1 | 1995 | 1901 | 0.000 |
Why?
|
Cytomegalovirus | 1 | 1990 | 756 | 0.000 |
Why?
|
C-Reactive Protein | 1 | 1996 | 3826 | 0.000 |
Why?
|
Risk | 1 | 1996 | 9610 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1997 | 11120 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1997 | 4024 | 0.000 |
Why?
|
Registries | 1 | 1996 | 8225 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1997 | 6345 | 0.000 |
Why?
|
Bacteria | 1 | 1990 | 2199 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1990 | 3156 | 0.000 |
Why?
|